The genomic correction efficiency of Dystrophin in DMD-iPSCs was 7.8% (4 clones out of 51) for crRNA DMD#9 and 14.6% (7 clones out of 48) for DMD#3. This evidence concerns the gene DMD and Duchenne muscular dystrophy.